Delta 9 Receives Extract Sales Authorization from Health Canada

WINNIPEG, Manitoba, Dec. 06, 2019 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: VRNDF) (a??Delta 9a?? or the a??Companya??), is pleased to announce that on December 4, 2019 it received an updated processing license from Health Canada. The license authorizes Delta 9 to sell cannabis extracts, cannabis topicals, and edible cannabis products as defined under the Cannabis Regulations (Canada). This development, following the Companya??s submission to Health Canada of new product notifications for nine (9) new derivative cannabis products on November 5, 2019, means the Company will be authorized to begin sales of cannabis extracts on January 5, 2020
a??This is an exciting milestone for us,a?? said John Arbuthnot, CEO of Delta 9, a??Our team has worked tirelessly toward our initial rollout of vaporizable oil cartridges, disposable vape oil pens, and dried cannabis extracts. We plan to begin shipments of these products early in the new year.a??Extract Product PortfolioDried Sift CannabisThe Company is currently developing its a??Sapphirea?? line of dried sift cannabis products for the recreational cannabis market which involves sifting the Companya??s blended products and refining them, leaving more of the high potency resin glands and less of the low potency plant material. The final product is a yellow/brownish powder and has a potency that is up to triple that of the whole flower dried cannabis materials. The Company plans to release dried sift products in the recreational cannabis market in the first quarter of 2020. Management expects that retail pricing for these products will be up to $25 per gram.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Февраль 2021    »